Briefs: Granules India

Granules India received approval from Brazilian Health Regulatory Agency ANVISA

First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl

Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl

Venus Remedies launches its flagship R&D drug Elores in Oman

The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025

Hikal receives Brazilian GMP certification and USFDA EIR for Bangalore and Panoli facilities

Mobile addicted generation heading towards hearing disorders: Survey

The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group

Fredun Pharmaceuticals achieves milestone in Pet Care Division

The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision

Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from 4 more countries

The company has secured 506 marketing approvals for its oncology products across 76 countries.

Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy

AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive

Unfortunate to see PM’s ‘Make in India’ dream being bulldozed

India brings traditional medicine at the forefront of India’s G20 presidency discourse: Amitabh Kant

Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts